Data / Drug companies / Viyash Life Sciences Private Limited
Viyash Life Sciences Private Limited: 47 products in the FDA NDC directory, labeler code 82245
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Viyash Life Sciences Private Limited (labeler code 82245) lists 47 products in the FDA National Drug Code Directory. By type: 47 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on January 1, 2026.
The request: Watch Viyash Life Sciences Private Limited (FDA labeler code 82245): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 82245
- Products in commercial distribution
- 47
- Packages
- 47
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule V 1
- Started marketing in the last 12 months
- 12
- Earliest marketing start
- January 1, 1982
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 47 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 47 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 45 | 95.7% |
| Liquid | 2 | 4.3% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Nilotinib premix | 82245-0220 | Powder | Bulk ingredients | January 1, 2026 |
| Edoxaban tosylate monohydrate | 82245-0219 | Powder | Bulk ingredients | January 1, 2026 |
| Deucravacitinib | 82245-0218 | Powder | Bulk ingredients | January 1, 2026 |
| Niraparib tosylate monohydrate | 82245-0217 | Powder | Bulk ingredients | January 1, 2026 |
| Finerenone | 82245-0216 | Powder | Bulk ingredients | January 1, 2026 |
| Mavacamten | 82245-0215 | Powder | Bulk ingredients | January 1, 2026 |
| Clomiphene citrate | 82245-0214 | Powder | Bulk ingredients | January 1, 2026 |
| Dapagliflozin propanediol monohydrate | 82245-0213 | Powder | Bulk ingredients | January 1, 2026 |
| Viloxazine hydrochloride | 82245-0212 | Powder | Bulk ingredients | January 1, 2026 |
| Sertraline hydrochloride (form-ii) | 82245-0211 | Powder | Bulk ingredients | January 1, 2026 |
| Vonoprazan fumarate | 82245-0210 | Powder | Bulk ingredients | January 1, 2026 |
| Lacosamide | 82245-0209 | Powder | Bulk ingredients | January 1, 2026 |
| Apixaban | 82245-0126 | Powder | Bulk ingredients | March 14, 2024 |
| Vilazodone hydrochloride | 82245-0125 | Powder | Bulk ingredients | March 14, 2024 |
| Linagliptin | 82245-0124 | Powder | Bulk ingredients | March 14, 2024 |
| Ivacaftor | 82245-0123 | Powder | Bulk ingredients | March 5, 2024 |
| Ticagrelor | 82245-0122 | Powder | Bulk ingredients | March 5, 2024 |
| Glycopyrrolate | 82245-0121 | Powder | Bulk ingredients | March 5, 2024 |
| Losartan potassium | 82245-0208 | Powder | Bulk ingredients | June 23, 2023 |
| Abacavir sulfate | 82245-0207 | Powder | Bulk ingredients | February 23, 2023 |
| Olmesartan medoxomil | 82245-0206 | Powder | Bulk ingredients | February 23, 2023 |
| Baclofen | 82245-0205 | Powder | Bulk ingredients | February 23, 2023 |
| Fingolimod hydrochloride | 82245-0106 | Powder | Bulk ingredients | May 11, 2018 |
| Roflumilast | 82245-0118 | Powder | Bulk ingredients | January 23, 2018 |
| Dolutegravir sodium | 82245-0202 | Powder | Bulk ingredients | June 9, 2016 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.